3 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow mesdopetam: new trials by email Literature Review of mesdopetam trials Research Report on mesdopetam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia Mesdopetam, Placebo - Parkinson Disease | Phase 2 | Completed | Integrative Research Laboratories AB | 155 | 2020-10-29 | 2024-03-06 |
| Efficacy and Tolerability of IRL790 in Parkinson's Disease Dyskinesia Mesdopetam (IRL790) - Parkinson Disease | Phase 2 | Completed | Integrative Research Laboratories AB | 75 | 2018-04-12 | 2022-03-31 |
| A Clinical Study of IRL790 in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia IRL790, Placebo - Parkinson Disease | Phase 1 / Phase 2 | Completed | Integrative Research Laboratories AB | 15 | 2016-11-08 | 2018-05-21 |
Integrative Research Laboratories AB (3)
France (1) · Israel (1) · Italy (1) · Poland (1) · Serbia (1) · Sweden (1) · United Kingdom (1) · United States (1)
Camille Carroll, MD (1) · Joakim Tedroff (1) · Per Svenningsson, MD, PhD (1)